By Fineline Cube The People’s Government of Pingshan District in Shenzhen has signed a cooperation framework agreement with Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196). This partnership aims to initiate a long-term and comprehensive strategic collaboration, leveraging innovative resources to cultivate and expand the biopharmaceutical, high-end medical device, and public health industries, and to carry out innovative R&D incubation and industrial empowerment.
Seizing Opportunities in the Guangdong–Hong Kong–Macao Greater Bay Area (GBA)
The partnership is designed to help Pingshan capitalize on the significant opportunities presented by the “dual zone” GBA, which encompasses Hong Kong, Macau, and several cities in Guangdong province. Biomedicine is a strategic pillar industry in this zone, and Shenzhen, as one of the first batch of national biopharmaceutical industry bases, is continuously accelerating the establishment of a research and industrialization system that is enterprise-led and integrates industry, academia, and research.
Shenzhen’s Commitment to Biomedical Growth
Shenzhen is committed to vigorously developing high-end medical devices, innovative drugs, and other research and development manufacturing sectors. The city aims to build the biopharmaceutical industry into a new economic growth engine and continues to actively promote investment and talent attraction within the biopharmaceutical sector. This strategic cooperation with Fosun Pharmaceutical is a step towards achieving these goals and enhancing the high-quality development of Shenzhen’s biomedical industry.-Fineline Info & Tech